- Contract Packaging
- Leaders in Packaging
Article | April 21, 2014
Aesica’s serialization services serve Chinese market
Its Italian finished dose manufacturing and packaging site’s anti-allergy packaging lines actively monitor the integrity and authenticity of products.
Aesica, the global pharmaceutical contract development and manufacturing organization (CDMO), has introduced serialization services and initiated commercial production of two anti-allergy product lines for the Chinese market at its Pianezza, Italy site, for a global, multinational client.
The packaging lines and associated serialization services are for the dedicated supply for one of Aesica’s strategic partners. The implementation took under six months to complete, with the first production of serialization batches just commenced.
The serialization packaging methods and processes comply with State Food and Drug Administration regulations set by the Ministry of Health of China and dovetailed with the partners coding requirements.
The serialization technology uses special digital techniques to check the linear barcode 128 and 20 digit serialized numbers. The code check is in full compliance with international ISO 15416 standards. The check system provides a reliable instrument for checking products and batches all the way through the packaging and distribution process.
The platform has capability for both thermal-transfer and thermal ink-jet printers for printing stickers with e-codes and variable data with 2D barcodes, respectively. High quality variable programming, inks suitable for a multiplicity of applications, and ribbons that comply with the latest legislative and environmental standards were all part of the installation.
Paolo Pizzorni, Senior Director at Aesica Pianezza commented, “We are delighted that our strategic partnership model has seen the successful development of two robust serialization packaging lines. For our customer this means improved patient safety with a reduced risk of competition from counterfeit products and the ability to detect expired drugs automatically. The end users are now able to verify the integrity and authenticity of the products dispensed to patients using a simple scan.
“China is a key geographic market that Western pharma companies seek to export to. At Aesica we are delighted to be providing serialization services to enable one of our customers to meet the technical and complex serialization regulations in this market.”
Related Sponsored Content
E-BOOK SPECIAL REPORT
The 2014 Trends Report
Sign up to receive timely updates from our editors and download this e-book consisting of our editors' picks of most notable package designs. Updated for 2014!